CLINICAL ROLE -
Atezolizumab and Nab-Paclitaxel for the Treatment of Triple-Negative Breast Cancer
Compared with other breast cancer subtypes, TNBC is more likely to be diagnosed in younger women and is more likely to have metastases present at the time of diagnosis.
Read More